Risk stratification for early-onset fetal growth restriction in women with abnormal serum biomarkers: a retrospective cohort study
Abstract Abnormal maternal serum biomarkers (AMSB), identified through the aneuploidy screening programme, are frequent incidental findings in pregnancy. They are associated with fetal growth restriction (FGR), but previous studies have not examined whether this association is with early-onset (<...
| Auteurs principaux: | , , , , , , , |
|---|---|
| Format: | Article |
| Langue: | English |
| Publié: |
Nature Portfolio
2020-12-01
|
| Collection: | Scientific Reports |
| Accès en ligne: | https://doi.org/10.1038/s41598-020-78631-5 |